Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “EPCAM”

42 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 42 results

Not applicableLooking for participantsNCT07450612
What this trial is testing

Liquid Biopsy and Machine Learning for Early Colorectal Cancer, Adenomas, Lynch Cancers, and Residual Disease Detection

Who this might be right for
Colorectal CancerAdenoma ColonAdenoma Colon Polyp+16 more
San Raffaele University 1,200
Early research (Phase 1)Looking for participantsNCT07492628
What this trial is testing

Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma

Who this might be right for
Bladder CancerUrothelial CarcinomaMetastatic Urothelial Carcinoma+2 more
Beijing Biotech 42
Not applicableUnknownNCT05703815
What this trial is testing

EpCAM and p53 Expressions in Infiltrating Duct Carcinoma of the Breast

Who this might be right for
Invasive Breast Cancer
Sohag University 40
Early research (Phase 1)Looking for participantsNCT05687682
What this trial is testing

Safety of AM-928 Infusion in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
AcadeMab Biomedical Inc. 38
Testing effectiveness (Phase 2)UnknownNCT03146637
What this trial is testing

Study of Activated CIK Armed With Bispecific Antibody for Advanced Liver Cancer

Who this might be right for
Advanced Liver Cancer
Benhealth Biopharmaceutical (Shenzhen) Co., Ltd. 80
Early research (Phase 1)Study completedNCT06386653
What this trial is testing

Molecular Imaging of EpCAM Receptors Using [123I]I-DARPIN-Ec1

Who this might be right for
Lung CancerOvarian Cancer
Tomsk National Research Medical Center of the Russian Academy of Sciences 10
Not applicableNot Yet RecruitingNCT07018505
What this trial is testing

EpCAM-Targeted Surface-Enhanced Raman Spectroscopy Nanotags for Rapid Evaluation of Surgical Margins and Sentinel Lymph Node Metastasis Status in Breast Cancers

Who this might be right for
Sentinel Lymph NodeBreast CancersMetastases+1 more
Yunnan Cancer Hospital 40
Early research (Phase 1)Looking for participantsNCT05808634
What this trial is testing

Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.

Who this might be right for
Advanced Adenocarcinoma
BioAtla, Inc. 168
Very early researchStudy completedNCT04379999
What this trial is testing

Atorvastatin ± Aspirin in Lynch Syndrome Syndrome

Who this might be right for
Lynch Syndrome
Fox Chase Cancer Center 43
Not applicableStudy completedNCT04290923
What this trial is testing

Determination of Blood Tumor Cells

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-CellAbnormalities Cell Epithelial
University of Zurich 71
Testing effectiveness (Phase 2)Study completedNCT00326885
What this trial is testing

Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites

Who this might be right for
Malignant Ascites
Neovii Biotech 32
Early research (Phase 1)Study completedNCT04501744
What this trial is testing

M701 (EpCAM and CD3) in Malignant Ascites

Who this might be right for
Malignant AscitesCancer
Wuhan YZY Biopharma Co., Ltd. 35
Testing effectiveness (Phase 2)Study completedNCT00464893
What this trial is testing

Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative Resection

Who this might be right for
Gastric CancerGastric Adenocarcinoma
Neovii Biotech 70
Not applicableLooking for participantsNCT05420064
What this trial is testing

An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk and An Intervention to Help Patients and Their Primary Care Providers Stay Up-to-date About Uncertain Genetic Test Results

Who this might be right for
BRCA1 MutationPOLD1 Gene MutationCDKN2A Mutation+19 more
Memorial Sloan Kettering Cancer Center 1,000
Not applicableActive Not RecruitingNCT04009148
What this trial is testing

Cascade Testing in Families With Newly Diagnosed Hereditary Breast and Ovarian Cancer Syndrome

Who this might be right for
BRCA-Mutated Ovarian CarcinomaBRIP1 Gene MutationMSH2 A636P+5 more
NYU Langone Health 118
Not applicableActive Not RecruitingNCT02760849
What this trial is testing

Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations

Who this might be right for
Deleterious BARD1 Gene MutationDeleterious BRCA1 Gene MutationDeleterious BRCA2 Gene Mutation+11 more
M.D. Anderson Cancer Center 374
Early research (Phase 1)Study completedNCT00635596
What this trial is testing

Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer

Who this might be right for
Solid Tumors
Amgen Research (Munich) GmbH 65
Early research (Phase 1)Study completedNCT00132522
What this trial is testing

EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide

Who this might be right for
Ovarian CancerColorectal CancerCarcinoma, Non-small-cell Lung+1 more
EMD Serono 45
Testing effectiveness (Phase 2)Study completedNCT00563836
What this trial is testing

Phase II Study of the Trifunctional Antibody Catumaxomab Administered Intra- and Postoperatively in Patients With Ovarian Cancer

Who this might be right for
Ovarian CancerEpithelial Ovarian Cancer
Neovii Biotech 41
Testing effectiveness (Phase 2)UnknownNCT03013712
What this trial is testing

A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer

Who this might be right for
Colon CancerEsophageal CarcinomaPancreatic Cancer+3 more
First Affiliated Hospital of Chengdu Medical College 60
Load More Results